Importance of the mindfulness technique in reducing levels of shortness of breath and improving the quality of life of patients with Lung Fibrosis

Authors
Category Primary study
Registry of TrialsBrazilian Registry of Clinical Trials
Year 2023
INTERVENTION: F04.754.137.750.500 This is a clinical, non‐blinded study, in which individuals will be randomly drawn into two groups: 1. Intervention group: participants (n=20) will meet for 08 consecutive weeks to carry out the IBM intervention, once a week, for 1 hour, online, via Google Meet. 2‐ Control group: participants (n=20) randomly selected for the control group will receive, in week 1, information about a healthy lifestyle, conscious eating, adequate sleep, responsibility for prescribed medications, trying to perform some regular physical activity during the week, set aside a moment of the day to reflect on your life and record some good event in a notebook or diary. CONDITION: C08.381.483.652 mindfulness PRIMARY OUTCOME: It is expected to find a reduction of at least 1 point on the mMRC dyspnea scale through the mindfulness‐based intervention SECONDARY OUTCOME: It is expected to find an increase of at least 15 points on the K‐BILD quality of life questionnaire after the intervention INCLUSION CRITERIA: Patients diagnosed with interstitial lung disease according to international guidelines. Dyspnea (mMRC>1). Aged over 18 years. Being followed up and treated at the interstitial lung diseaseOutpatient Clinic of the Hospital das Clínicas da Universidade Federal de Minas Gerais
Epistemonikos ID: 425a12557ac228b6bf908c6a657dd9097ed878f2
First added on: Feb 20, 2024